These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5901)

  • 1. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
    Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L
    Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH; Kolakowska T; McNeilly AS; Mandelbrote BM; Gelder MG
    Psychol Med; 1976 Aug; 6(3):407-15. PubMed ID: 996201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma chlorpromazine concentrations in children with behavioral disorders and mental illness.
    Rivera-Calimlim L; Griesbach PH; Perlmutter R
    Clin Pharmacol Ther; 1979 Jul; 26(1):114-21. PubMed ID: 445954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in therapeutic blood monitoring of chlorpromazine.
    Rivera-Calimlim L
    Ther Drug Monit; 1982; 4(1):41-9. PubMed ID: 7041337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
    Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
    Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of carbamazepine in acute psychosis: a controlled study.
    Lenzi A; Lazzerini F; Grossi E; Massimetti G; Placidi GF
    J Int Med Res; 1986; 14(2):78-84. PubMed ID: 3084316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
    Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
    Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
    Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lithium on plasma chlorpromazine levels.
    Rivera-Calimlim L; Kerzner B; Karch FE
    Clin Pharmacol Ther; 1978 Apr; 23(4):451-5. PubMed ID: 630793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
    Phillipson OT; McKeown JM; Baker J; Healey AF
    Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B; Alfredsson G
    Psychopharmacology (Berl); 1981; 73(1):55-62. PubMed ID: 6785790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.